Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 2/20 | 0.48 |
| ▸ | DNPH1 | O43598 | 7/20 | 0.44 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.44 |
| ▸ | P2RY2 | P41231 | 2/20 | 0.40 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.40 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.40 |
| ▸ | AMDHD2 | Q9Y303 | 1/20 | 0.40 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.40 |
| ▸ | ATIC | P31939 | 1/20 | 0.40 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.40 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.40 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.39 |
| ▸ | LDHA | P00338 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29508765 | 1.00 | FBP1 (0.48) | FBP1DNPH1P2RY12P2RY2SIRT2 | |
| SCHEMBL14742691 | 1.00 | FBP1 (0.48) | FBP1DNPH1P2RY12P2RY2SIRT2 | |
| Pyrophosphoric Acid SCHEMBL14742591 | 0.97 | FBP1 (0.45) | FBP1DNPH1P2RY12P2RY2SIRT2 | |
| SCHEMBL2818963 | 0.83 | FBP1 (0.55) | FBP1DNPH1P2RY12P2RY2AMDHD2 | |
| SCHEMBL1513025 | 0.83 | FBP1 (0.55) | FBP1DNPH1P2RY12P2RY2AMDHD2 | |
| SCHEMBL3290451 | 0.81 | SLC5A2 (0.53) | — | |
| SCHEMBL379657 | 0.78 | ADORA1 (0.41) | — | |
| SCHEMBL5922579 | 0.78 | FBP1 (0.49) | FBP1DNPH1P2RY12P2RY2ATIC | |
| SCHEMBL851261 | 0.74 | DHODH (0.37) | — | |
| SCHEMBL30853963 | 0.72 | FBP1 (0.48) | FBP1DNPH1P2RY2SIRT2SIRT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260092179-A1 | GENETICALLY MODIFIED HOST CELLS PRODUCING VIOLACEIN, ANALOGUES, AND DERIVATIVES THEREOF | OCTARINE BIO APS (DK) | 2026-04-02 | — | — | US | claimed |
| US-20240254533-A1 | METHODS FOR PRODUCING TRYPTAMINE DERIVATIVES | OCTARINE BIO APS (DK) | 2024-08-01 | — | — | US | claimed |
| EP-4347856-A2 | METHODS FOR PRODUCING TRYPTAMINE DERIVATIVES | Octarine Bio ApS (DK) | 2024-04-10 | — | — | EP | claimed |
| WO-2024068434-A2 | GENETICALLY MODIFIED HOST CELLS PRODUCING VIOLACEIN, ANALOGUES, AND DERIVATIVES THEREOF | OCTARINE BIO APS (DK) | 2024-04-04 | — | — | WO | claimed |
| WO-2022248635-A2 | METHODS FOR PRODUCING TRYPTAMINE DERIVATIVES. | OCTARINE BIO APS (DK) | 2022-12-01 | — | — | WO | claimed |
| US-20190032014-A1 | USING MICROBIOTA METABOLITES TO DIFFERENTIATE NAÏVE T-CELLS AND RELATED METHODS TO INDUCE OR PREVENT INFLAMMATORY CONDITIONS | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2019-01-31 | — | — | US | claimed |
| EP-3430128-A1 | USING MICROBIOTA METABOLITES OT DIFFERENTIATE NAIVE T-CELLS AND RELATED METHODS TO INDUCE OR PREVENT INFLAMMATORY CONDITIONS | The Texas A&M University System (US) | 2019-01-23 | — | — | EP | claimed |
| WO-2017161268-A1 | USING MICROBIOTA METABOLITES OT DIFFERENTIATE NAIVE T-CELLS AND RELATED METHODS TO INDUCE OR PREVENT INFLAMMATORY CONDITIONS | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2017-09-21 | — | — | WO | claimed |
| US-20150299742-A1 | COMPOSITIONS AND METHODS FOR ENHANCING TOLERANCE FOR THE PRODUCTION OF ORGANIC CHEMICALS PRODUCED BY MICROORGANISMS | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2015-10-22 | — | — | US | claimed |
| US-20100210017-A1 | COMPOSITIONS AND METHODS FOR ENHANCING TOLERANCE FOR THE PRODUCTION OF ORGANIC CHEMICALS PRODUCED BY MICROORGANISMS | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2010-08-19 | — | — | US | claimed |
| EP-2126042-A2 | COMPOSITIONS AND METHODS FOR ENHANCING TOLERANCE FOR THE PRODUCTION OF ORGANIC CHEMICALS PRODUCED BY MICROORGANISMS | The Regents of the University of Colorado (US) | 2009-12-02 | — | — | EP | claimed |
| WO-2008089102-A2 | COMPOSITIONS AND METHODS FOR ENHANCING TOLERANCE FOR THE PRODUCTION OF ORGANIC CHEMICALS PRODUCED BY MICROORGANISMS | REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2008-07-24 | — | — | WO | claimed |
| EP-4739326-A2 | PRODUCTION & SECRETION OF AUXIN-LIKE MOLECULES IN BACTERIA | SNIPR Biome ApS (DK) | 2026-05-13 | — | — | EP | disclosed |
| EP-4739777-A1 | TRANSMISSIBLE ELEMENTS COMPRISING PATHWAY MODIFICATION SYSTEMS AND EXOGENOUS NUCLEIC ACIDS FOR THE PRODUCTION OF MOLECULES OF INTEREST | SNIPR Biome ApS (DK) | 2026-05-13 | — | — | EP | disclosed |
| US-20260125432-A1 | MALTOSE DEPENDENT DEGRONS, MALTOSE-RESPONSIVE PROMOTERS, STABILIZATION CONSTRUCTS, AND THEIR USE IN PRODUCTION OF NON-CATABOLIC COMPOUNDS | AMYRIS INC (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260115234-A1 | PRODUCTION & SECRETION OF AUXIN-LIKE MOLECULES IN BACTERIA | SNIPR BIOME APS (DK) | 2026-04-30 | — | — | US | disclosed |
| EP-0698218-A1 | LABELLED CARBOHYDRATES AND THEIR USE IN ASSAYS | Oxford GlycoSciences (UK) Limited (GB) | 1996-02-28 | — | — | EP | disclosed |
| WO-1994028423-A1 | LABELLED CARBOHYDRATES AND THEIR USE IN ASSAYS | OXFORD GLYCOSYSTEMS LTD. (GB) | 1994-12-08 | — | — | WO | disclosed |
| EP-0608722-A1 | Biological screens for detection of herbicides | AMERICAN CYANAMID COMPANY (US) | 1994-08-03 | — | — | EP | disclosed |
| US-5034318-A | Culturing Coryneform glutamic acid producing bacteria with plasmids | AJINOMOTO CO., INC. (JP) | 1991-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125432-A1 | MALTOSE DEPENDENT DEGRONS, MALTOSE-RESPONSIVE PROMOTERS, STABILIZATION CONSTRUCTS, AND THEIR USE IN PRODUCTION OF NON-CATABOLIC COMPOUNDS | MAX, JUND, MYCBP | FBP1 38/4885DNPH1 2236/4885P2RY12 4753/4885 |
| US-20260115234-A1 | PRODUCTION & SECRETION OF AUXIN-LIKE MOLECULES IN BACTERIA | AADAT, NAT1, IDO1 | FBP1 66/4885DNPH1 2901/4885P2RY12 3065/4885 |
| US-20260092179-A1 | GENETICALLY MODIFIED HOST CELLS PRODUCING VIOLACEIN, ANALOGUES, AND DERIVATIVES THEREOF | TDO2, BLVRB, INMT | FBP1 1134/4885DNPH1 2663/4885P2RY12 4376/4885 |
| US-20190032014-A1 | USING MICROBIOTA METABOLITES TO DIFFERENTIATE NAÏVE T-CELLS AND RELATED METHODS TO INDUCE OR PREVENT INFLAMMATORY CONDITIONS | CD69, CD14, IL17A | FBP1 2571/4885DNPH1 1379/4885P2RY12 2002/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.